Retrophin to acquire Transcept Pharmaceuticals - MarketLine Financial Deals

Retrophin to acquire Transcept Pharmaceuticals

Retrophin to acquire Transcept Pharmaceuticals - MarketLine Financial Deals
Retrophin to acquire Transcept Pharmaceuticals
Published Sep 18, 2013
3 pages — Published Sep 18, 2013
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Retrophin, Inc., a biotechnology company, has made an offer to acquire Transcept Pharmaceuticals, Inc, a specialty pharmaceutical company.

  
Source:
Document ID
MA142007_130920
Country
Ticker
RTRX=US
Ticker
TSPT=US
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Retrophin to acquire Transcept Pharmaceuticals" Sep 18, 2013. Alacra Store. Dec 07, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Retrophin-to-acquire-Transcept-Pharmaceuticals-2052-97639>
  
APA:
MarketLine Financial Deals. (2013). Retrophin to acquire Transcept Pharmaceuticals Sep 18, 2013. New York, NY: Alacra Store. Retrieved Dec 07, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Retrophin-to-acquire-Transcept-Pharmaceuticals-2052-97639>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.